000566 海南海药
已收盘 04-15 15:00:00
资讯
新帖
简况
海南海药(000566)2025年年报简析:亏损收窄,短期债务压力上升
证券之星 · 04-12
海南海药(000566)2025年年报简析:亏损收窄,短期债务压力上升
海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%
证券之星 · 04-11
海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%
图解海南海药年报:第四季度单季净利润同比增长84.74%
证券之星 · 04-11
图解海南海药年报:第四季度单季净利润同比增长84.74%
海南海药(000566)披露出售股票资产公告,4月7日股价上涨1.31%
证券之星 · 04-07
海南海药(000566)披露出售股票资产公告,4月7日股价上涨1.31%
海南海药拟减持中国抗体不超5%股份
财中社 · 04-03
海南海药拟减持中国抗体不超5%股份
海南海药:截至2026年2月28日公司股东户数为122,506
证券之星 · 03-12
海南海药:截至2026年2月28日公司股东户数为122,506
股市必读:海南海药(000566)今年截至3月3日累计跌幅已超20%
证券之星 · 03-04
股市必读:海南海药(000566)今年截至3月3日累计跌幅已超20%
海南海药(000566)披露关于召开2026年第一次临时股东会的通知,2月25日股价上涨1.74%
证券之星 · 02-25
海南海药(000566)披露关于召开2026年第一次临时股东会的通知,2月25日股价上涨1.74%
海南海药(000566)2月10日股东户数12.45万户,较上期减少3.32%
证券之星 · 02-24
海南海药(000566)2月10日股东户数12.45万户,较上期减少3.32%
2月4日海南海药发布公告,股东减持342.73万股
中金财经 · 02-04
2月4日海南海药发布公告,股东减持342.73万股
海南海药最新公告:副总经理张晖因到龄退休辞职
证券之星 · 02-04
海南海药最新公告:副总经理张晖因到龄退休辞职
股市必读:海南海药(000566)预计2025年全年扣除后营业收入:78,000万元至88,000万元
证券之星 · 02-02
股市必读:海南海药(000566)预计2025年全年扣除后营业收入:78,000万元至88,000万元
海南海药最新公告:预计2025年净亏损3.50亿元-4.30亿元
证券之星 · 01-30
海南海药最新公告:预计2025年净亏损3.50亿元-4.30亿元
海南海药:加快新产品上市与创新药研发
证券之星 · 01-22
海南海药:加快新产品上市与创新药研发
海南海药最新公告:创新药派恩加滨片Ⅱa期临床试验研究结果发布
证券之星 · 01-09
海南海药最新公告:创新药派恩加滨片Ⅱa期临床试验研究结果发布
海南海药:股东云南国际信托拟减持不超过1%
新京报 · 01-09
海南海药:股东云南国际信托拟减持不超过1%
异动快报:海南海药(000566)1月8日9点37分触及涨停板
证券之星 · 01-08
异动快报:海南海药(000566)1月8日9点37分触及涨停板
海南海药:截至2025年12月31日股东户数为129,547
证券之星 · 01-07
海南海药:截至2025年12月31日股东户数为129,547
海南海药(000566)1.31亿股限售股将于12月26日解禁,占总股本10.08%
证券之星 · 2025-12-26
海南海药(000566)1.31亿股限售股将于12月26日解禁,占总股本10.08%
海南海药:公司目前未触及退市风险警示规定情形
证券之星 · 2025-12-24
海南海药:公司目前未触及退市风险警示规定情形
加载更多
公司概况
公司名称:
海南海药股份有限公司
所属行业:
医药制造业
上市日期:
1994-05-25
主营业务:
海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是注射用头孢西丁钠、注射用头孢唑肟钠、注射用美罗培南、注射用氨曲南、注射用头孢呋辛钠、注射用头孢曲松钠、盐酸米诺环素胶囊、头孢克洛颗粒、头孢克洛干混悬剂、注射用头孢美唑钠、肠胃康系列(颗粒剂、片剂)、枫蓼肠胃康口服液、枫蓼肠胃康分散片、聚乙二醇4000散、富马酸伏诺拉生片、醋氨己酸锌胶囊、紫杉醇注射液、复方红豆杉胶囊、7-ANCA、4-AA、头孢西丁钠、头孢西丁酸、头孢唑肟钠、氨曲南、美罗培南、地氯雷他定口服溶液、注射用维生素C、小柴胡颗粒、红宝牌太和胶囊、双参活血通络颗粒、罗沙司他胶囊、利奈唑胺片、Crystaderm。
发行价格:
5.80
{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":5.47,"timestamp":1776236595000,"preClose":5.36,"halted":0,"volume":40803200,"delay":0,"changeRate":0.0205,"floatShares":1297000000,"shares":1297000000,"eps":0.5128,"marketStatus":"已收盘","change":0.11,"latestTime":"04-15 15:00:00","open":5.46,"high":5.54,"low":5.36,"amount":222000000,"amplitude":0.0336,"askPrice":5.47,"askSize":5203,"bidPrice":5.46,"bidSize":2836,"shortable":0,"etf":0,"ttmEps":0.5128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776303000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.36,"symbolType":"stock","openAndCloseTimeList":[[1776216600000,1776223800000],[1776229200000,1776236400000]],"highLimit":5.9,"lowLimit":4.82,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"isCdr":false,"pbRate":85.04,"roa":"--","peRate":10.666927,"roe":"--","epsLYR":-0.3314,"committee":-0.516012,"marketValue":7097000000,"turnoverRate":0.0315,"status":0,"floatMarketCap":7093000000},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2626120276","title":"海南海药(000566)2025年年报简析:亏损收窄,短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2626120276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626120276?lang=zh_cn&edition=full","pubTime":"2026-04-12 06:05","pubTimestamp":1775945131,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期海南海药发布2025年年报。本报告期海南海药短期债务压力上升,流动比率达0.31。其中,毛利率24.8%,同比减29.59%,净利率-54.88%,同比增65.91%,销售费用、管理费用、财务费用总计5.71亿元,三费占营收比68.66%,同比增0.25%,每股净资产0.06元,同比减84.43%,每股经营性现金流0.06元,同比增554.67%,每股收益-0.33元,同比增71.81%证券之星价投圈财报分析工具显示:业务评价:去年的净利率为-54.88%,算上全部成本后,公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0060","BK0070","BK0146","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626128090","title":"海南海药(000566)3月31日股东户数11.29万户,较上期减少3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2626128090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626128090?lang=zh_cn&edition=full","pubTime":"2026-04-11 17:03","pubTimestamp":1775898218,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海南海药披露,截至2026年3月31日公司股东户数为11.29万户,较3月10日减少4598.0户,减幅为3.91%。在化学制药行业个股中,海南海药股东户数高于行业平均水平,截至3月31日,化学制药行业平均股东户数为3.45万户。从股价来看,2026年3月10日至2026年3月31日,海南海药区间跌幅为5.23%,在此期间股东户数减少4598.0户,减幅为3.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100013115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0060","BK0070","BK0239","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626114497","title":"图解海南海药年报:第四季度单季净利润同比增长84.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2626114497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626114497?lang=zh_cn&edition=full","pubTime":"2026-04-11 00:48","pubTimestamp":1775839728,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药2025年年报显示,当年度公司主营收入8.31亿元,同比下降16.1%;归母净利润-4.3亿元,同比上升71.81%;扣非净利润-4.7亿元,同比上升60.64%;其中2025年第四季度,公司单季度主营收入1.91亿元,同比上升2.97%;单季度归母净利润-1.88亿元,同比上升84.74%;单季度扣非净利润-1.98亿元,同比上升79.05%;负债率97.9%,投资收益-441.96万元,财务费用1.92亿元,毛利率24.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100001188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625554939","title":"海南海药(000566)披露出售股票资产公告,4月7日股价上涨1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625554939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625554939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:34","pubTimestamp":1775554458,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,海南海药报收于5.4元,较前一交易日上涨1.31%,最新总市值为70.06亿元。近日,海南海药股份有限公司发布《关于出售股票资产的公告》。公告显示,公司拟通过集中竞价交易及大宗交易方式减持其持有的中国抗体制药有限公司股份,合计不超过6800万股,占其总股本比例不超过5%。公司持有中国抗体15888.21万股,占总股本的11.46%,股份权属清晰,不存在质押、冻结等情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0188","BK0070","BK0146","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500126","title":"海南海药拟减持中国抗体不超5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500126","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624500126?lang=zh_cn&edition=full","pubTime":"2026-04-03 20:57","pubTimestamp":1775221020,"startTime":"0","endTime":"0","summary":"4月3日,海南海药(000566)发布公告,公司拟通过集中竞价交易及大宗交易的方式减持中国抗体(03681)股份数量不超过6800万股,不超过公司总股本的5%。截至公告披露日前一交易日,公司持有中国抗体1.59亿股股票资产的市值约为2.8亿港元,此次交易旨在优化公司资产结构,提高资产流动性及使用效率。2025年前三季度,海南海药实现收入6.40亿元,归母净利润-2.42亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695191451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000566","BK0070","BK0188","BK1574","03681","BK0146","BK1161","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132294","title":"海南海药:截至2026年2月28日公司股东户数为122,506","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618132294?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:51","pubTimestamp":1773319889,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘你好,请问截止2026年2月28日股东人数是多少?谢谢海南海药回复:您好,截至2026年2月28日公司股东户数为122,506。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200036753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0146","BK0239","BK0070","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332373","title":"股市必读:海南海药(000566)今年截至3月3日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332373","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616332373?lang=zh_cn&edition=full","pubTime":"2026-03-04 02:17","pubTimestamp":1772561832,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘,海南海药报收于5.61元,下跌3.28%,换手率3.22%,成交量41.73万手,成交额2.39亿元。来自交易信息汇总:前10个交易日主力资金累计净流出2.53亿元,期间股价累计下跌11.82%。交易信息汇总3月3日海南海药收盘报5.61元,跌3.28%,当日成交4173.45万元。该股已连续2日下跌,当年累计跌幅20.85%。当日资金流向:主力资金净流出1879.39万元,游资资金净流出1081.11万元,散户资金净流入2960.5万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400001276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0070","BK0060","BK0188","BK0239","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614337110","title":"海南海药(000566)披露关于召开2026年第一次临时股东会的通知,2月25日股价上涨1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614337110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614337110?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:30","pubTimestamp":1772029848,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,海南海药报收于6.45元,较前一交易日上涨1.74%,最新总市值为83.68亿元。近日,海南海药股份有限公司披露《关于召开2026年第一次临时股东会的通知》。公告显示,公司将于2026年3月13日召开2026年第一次临时股东会,会议由董事会召集,现场会议时间为当日15:00,网络投票时间为同日9:15至15:00。相关议案已获第十一届董事会第三十一次会议审议通过。关联股东需回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500038220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0146","BK0239","000566","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613782799","title":"海南海药(000566)2月10日股东户数12.45万户,较上期减少3.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613782799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613782799?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:19","pubTimestamp":1771924764,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海南海药披露,截至2026年2月10日公司股东户数为12.45万户,较1月31日减少4272.0户,减幅为3.32%。在化学制药行业个股中,海南海药股东户数高于行业平均水平,截至2月10日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月31日至2026年2月10日,海南海药区间跌幅为0.93%,在此期间股东户数减少4272.0户,减幅为3.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400032256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0146","BK0070","000566","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608633143","title":"2月4日海南海药发布公告,股东减持342.73万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608633143","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608633143?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:16","pubTimestamp":1770203794,"startTime":"0","endTime":"0","summary":"证券之星消息,2月4日海南海药发布公告《海南海药:简式权益变动报告书(云南国际信托有限公司-聚利36号单一资金信托)》,其股东云南国际信托有限公司-聚利36号单一资金信托于2026年2月2日合计减持342.73万股,占公司目前总股本的0.2642%,变动期间该股股价下跌3.87%,截止2月2日收盘报6.21元。股东增减持详情见下表: 根据海南海药2025年三季报公布的十大股东详情如下: 为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/04/20260204931582.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/04/20260204931582.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260204/31998547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0070","BK0188","BK0060","BK0239","000566","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608132350","title":"海南海药最新公告:副总经理张晖因到龄退休辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2608132350","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608132350?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:39","pubTimestamp":1770201577,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称,公司董事会近日收到副总经理张晖的辞职报告,其因到龄退休申请辞去公司副总经理职务。辞职后,张晖将不再担任海南海药任何职务。张晖现持有公司股份365,372股,辞职后其持有的公司股份将继续按照相关规定进行管理。海南海药及董事会对张晖在任职期间的贡献表示感谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400034330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0070","BK0239","BK0188","000566","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608884857","title":"股市必读:海南海药(000566)预计2025年全年扣除后营业收入:78,000万元至88,000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608884857?lang=zh_cn&edition=full","pubTime":"2026-02-02 05:12","pubTimestamp":1769980335,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,海南海药报收于6.46元,上涨0.31%,换手率2.93%,成交量38.0万手,成交额2.47亿元。业绩披露要点业绩预告海南海药发布业绩预告,预计2025年全年扣非后净利润亏损3.8亿元至4.8亿元。预计2025年全年扣除后营业收入7.8亿元至8.8亿元。公司公告汇总2025年度业绩预告海南海药预计2025年度归属于上市公司股东的净利润亏损35,000万元至43,000万元,亏损额较上年同期下降。具体财务数据以2025年年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607043081","title":"海南海药最新公告:预计2025年净亏损3.50亿元-4.30亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607043081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607043081?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:09","pubTimestamp":1769778562,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称,预计2025年归属于上市公司股东的净利润为亏损35,000万元至43,000万元。业绩变动主要原因系销售费用、信用减值损失、公允价值变动损失、资产减值损失同比减少,以及投资收益同比上升所致。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000044691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000566","BK0070","BK0188","BK0239","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605496010","title":"海南海药:加快新产品上市与创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2605496010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605496010?lang=zh_cn&edition=full","pubTime":"2026-01-22 20:52","pubTimestamp":1769086376,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药01月22日在投资者关系平台上答复投资者关心的问题。公司正在努力提升经营业绩为股东创造价值,感谢您的理解和关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200038615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06978","BK1574","BK0188","BK0146","BK0239","000566","159992","BK0070","BK0060","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602754883","title":"海南海药最新公告:创新药派恩加滨片Ⅱa期临床试验研究结果发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2602754883","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602754883?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:50","pubTimestamp":1767963010,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称,公司全资子公司海口市制药厂有限公司与中国科学院上海药物研究所联合研究开发的创新药派恩加滨项目,于近日完成了Ⅱa期临床试验,初步研究结果显示达到主要及次要临床终点。派恩加滨属于化药1类,为新型抗癫痫药物,新一代KCNQ钾通道激动剂,目前全球尚无上市品种,本品可用于难治性癫痫的治疗。本次仅为派恩加滨完成中国Ⅱa期临床试验结果分析,后续尚需完成Ⅱb期及Ⅲ期临床试验,并经国家药监局批准后方可上市。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900038074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","BK0188","000566","BK1161","06978","BK0070","BK0146","159992","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602737293","title":"海南海药:股东云南国际信托拟减持不超过1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602737293","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602737293?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:31","pubTimestamp":1767961860,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 1月9日,海南海药公告,持股5%以上股东云南国际信托有限公司-聚利36号单一资金信托持有公司6829.55万股,占5.26%,因资金需求,拟于本公告披露之日起15个交易日后的连续90个自然日内,以集中竞价方式减持不超过1297.37万股,占1%;股份来源为要约收购所得,减持价格将按届时市场价确定。","market":"sh","thumbnail":"https://media.bjnews.com.cn/cover/2026/01/07/5673058989907193474.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/01/07/5673058989907193474.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1767961393129047.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1767961393129047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0060","BK0188","BK0146","000566","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601335586","title":"异动快报:海南海药(000566)1月8日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601335586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601335586?lang=zh_cn&edition=full","pubTime":"2026-01-08 09:41","pubTimestamp":1767836480,"startTime":"0","endTime":"0","summary":"证券之星1月8日盘中消息,9点37分海南海药触及涨停板。其所属行业化学制药目前上涨。领涨股为必贝特。该股为创新药,化学原料药,医药概念热股,当日创新药概念上涨1.02%,化学原料药概念上涨0.91%,医药概念上涨0.78%。1月7日的资金流向数据方面,主力资金净流出6692.61万元,占总成交额9.79%,游资资金净流出894.93万元,占总成交额1.31%,散户资金净流入7587.54万元,占总成交额11.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800008170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0070","BK0188","BK0060","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601209738","title":"海南海药:截至2025年12月31日股东户数为129,547","url":"https://stock-news.laohu8.com/highlight/detail?id=2601209738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601209738?lang=zh_cn&edition=full","pubTime":"2026-01-07 15:51","pubTimestamp":1767772273,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药(000566)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘:请问截止到2025年12月31日,股东户数是多少?谢谢海南海药回复:您好,截至2025年12月31日公司股东户数为129,547。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700018589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0070","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594252848","title":"海南海药(000566)1.31亿股限售股将于12月26日解禁,占总股本10.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252848","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594252848?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:11","pubTimestamp":1766707876,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,海南海药于12月26日将有1.31亿股限售股份解禁,为公司定向增发机构配售股份,占公司总股本10.08%。本次解禁后,公司还有62.95万股限售股份,占总股本0.05%。海南海药主营业务:药品及医疗器械研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600003628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","000566","BK0070","BK0146","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593447239","title":"海南海药:公司目前未触及退市风险警示规定情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447239?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:52","pubTimestamp":1766580733,"startTime":"0","endTime":"0","summary":"证券之星消息,海南海药12月23日在投资者关系平台上答复投资者关心的问题。我们给一个答复海南海药回复:您好,根据《深圳证券交易所股票上市规则》第九章相关规定:\"上市公司最近一个会计年度经审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值,且扣除后的营业收入低于3亿元。\"深交所对其股票交易实施退市风险警示。公司目前未触及上述规定情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000566","BK0070","BK0060","BK0239","BK0146"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776273601772,"stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.0267},{"period":"3month","weight":-0.1968},{"period":"6month","weight":-0.0713},{"period":"1year","weight":0.1372},{"period":"ytd","weight":-0.235}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":-0.0141},{"period":"3month","weight":-0.0208},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南海药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"112860人(较上一季度减少3.91%)","perCapita":"11489股","listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","registeredCapital":"129736万元","survey":" 海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是注射用头孢西丁钠、注射用头孢唑肟钠、注射用美罗培南、注射用氨曲南、注射用头孢呋辛钠、注射用头孢曲松钠、盐酸米诺环素胶囊、头孢克洛颗粒、头孢克洛干混悬剂、注射用头孢美唑钠、肠胃康系列(颗粒剂、片剂)、枫蓼肠胃康口服液、枫蓼肠胃康分散片、聚乙二醇4000散、富马酸伏诺拉生片、醋氨己酸锌胶囊、紫杉醇注射液、复方红豆杉胶囊、7-ANCA、4-AA、头孢西丁钠、头孢西丁酸、头孢唑肟钠、氨曲南、美罗培南、地氯雷他定口服溶液、注射用维生素C、小柴胡颗粒、红宝牌太和胶囊、双参活血通络颗粒、罗沙司他胶囊、利奈唑胺片、Crystaderm。","listedPrice":5.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}